0000899140-24-001053.txt : 20241002
0000899140-24-001053.hdr.sgml : 20241002
20241002135747
ACCESSION NUMBER: 0000899140-24-001053
CONFORMED SUBMISSION TYPE: N-PX
PUBLIC DOCUMENT COUNT: 2
CONFORMED PERIOD OF REPORT: 20240630
FILED AS OF DATE: 20241002
EFFECTIVENESS DATE: 20241002
FILER:
COMPANY DATA:
COMPANY CONFORMED NAME: Duquesne Family Office LLC
CENTRAL INDEX KEY: 0001536411
ORGANIZATION NAME:
IRS NUMBER: 273934850
STATE OF INCORPORATION: DE
FILING VALUES:
FORM TYPE: N-PX
SEC ACT: 1934 Act
SEC FILE NUMBER: 028-14660
FILM NUMBER: 241346375
BUSINESS ADDRESS:
STREET 1: 40 WEST 57TH STREET, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
BUSINESS PHONE: (212) 830-6500
MAIL ADDRESS:
STREET 1: 40 WEST 57TH STREET, 25TH FLOOR
CITY: NEW YORK
STATE: NY
ZIP: 10019
N-PX
1
primary_doc.xml
N-PX
IM
LIVE
0001536411
XXXXXXXX
06/30/2024
YEAR
2024
Duquesne Family Office LLC
212-830-6500
40 WEST 57TH STREET, 25TH FLOOR
NEW YORK
NY
10019
Sue Meng
40 WEST 57TH STREET, 25TH FLOOR
NEW YORK
NY
10019
INSTITUTIONAL MANAGER VOTING REPORT
N
028-14660
5493003OVSMJMOFRLY57
0
Duquesne Family Office LLC
Sue Meng
Sue Meng
General Counsel
10/02/2024
PROXY VOTING RECORD
2
votetable.xml
NVIDIA Corp67066G104US67066G1040BBG000BBJQV006/26/2024Advisory approval of our executive compensation.SECTION 14A SAY-ON-PAY VOTES1121980FOR112198FOR
Bridgebio Pharma Inc10806X102US10806X1028BBG00P9KDZK606/21/2024To cast a non-binding, advisory vote to approve the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES1755000FOR175500FOR
Bridgebio Pharma Inc10806X102US10806X1028BBG00P9KDZK606/21/2024To approve an amendment and restatement of the 2021 Amended and Restated BridgeBio Pharma, Inc. Stock Option and Incentive Plan to, among other things, increase the number of shares of common stock reserved for issuance thereunder by 6,500,000 shares.SECTION 14A SAY-ON-PAY VOTES1755000FOR175500FOR
Marvell Technology Inc573874104US5738741041BBG00ZXBJ15306/20/2024An advisory (non-binding) vote to approve compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES6176750FOR617675FOR
Vertiv Holdings Co92537N108US92537N1081BBG00L2B8KW806/19/2024To approve, on an advisory basis, the 2023 compensation of our named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES4025750FOR402575FOR
TG Therapeutics Inc88322Q108US88322Q1085BBG000FVZQY106/14/2024An advisory vote to approve the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES2800000FOR280000FOR
TG Therapeutics Inc88322Q108US88322Q1085BBG000FVZQY106/14/2024To approve an amendment to the Company's 2022 Incentive Plan to remove full-value awards limit.SECTION 14A SAY-ON-PAY VOTES2800000FOR280000FOR
Coupang Inc22266T109US22266T1097BBG00XMJRPQ806/13/2024To consider a non-binding vote to approve the compensation of Coupang, Inc.'s named executive officers.SECTION 14A SAY-ON-PAY VOTES87777540FOR8777754FOR
Natera Inc632307104US6323071042BBG001J1BQ8606/12/2024To approve, on an advisory (non-binding) basis, the compensation of Natera, Inc.'s named executive officers as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES19293800AGAINST1929380AGAINST
Natera Inc632307104US6323071042BBG001J1BQ8606/12/2024To approve Natera, Inc.'s amended and restated 2015 Equity Incentive Plan.SECTION 14A SAY-ON-PAY VOTES19293800AGAINST1929380AGAINST
Veracyte Inc92337F107US92337F1075BBG001J2M54206/12/2024The approval, on a non-binding advisory basis, of the compensation of our named executive officers, as disclosed in our proxy statement.SECTION 14A SAY-ON-PAY VOTES2599440FOR259944FOR
Veracyte Inc92337F107US92337F1075BBG001J2M54206/12/2024The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan.SECTION 14A SAY-ON-PAY VOTES2599440FOR259944FOR
Freeport-McMoRan Inc35671D857US35671D8570BBG000BJDB1506/11/2024Approval, on an advisory basis, of the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES13788750FOR1378875FOR
Arista Networks Inc040413106US0404131064BBG000N2HDY506/07/2024Approval, on an advisory basis, of the compensation of the named executive officers.SECTION 14A SAY-ON-PAY VOTES4115520FOR411552FOR
Arista Networks Inc040413106US0404131064BBG000N2HDY506/07/2024Approval of the Amended, Restated and Extended 2014 Equity Incentive Plan.SECTION 14A SAY-ON-PAY VOTES4115520FOR411552FOR
Crinetics Pharmaceuticals Inc22663K107US22663K1079BBG00BC5922406/07/2024To consider and vote upon, on an advisory basis, the compensation of the Company's named executive officers as disclosed in the proxy statement pursuant to the compensation disclosure rules of the Securities and Exchange Commission.SECTION 14A SAY-ON-PAY VOTES3090000FOR309000FOR
MoonLake Immunotherapeutics61559X104KY61559X1045BBG00XQZQTS906/05/2024Approval of, on an advisory basis, the compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES875000FOR87500FOR
MoonLake Immunotherapeutics61559X104KY61559X1045BBG00XQZQTS906/05/2024Non-binding advisory vote on the frequency of future advisory votes on executive compensation.SECTION 14A SAY-ON-PAY VOTES8750001 Year87500FOR
Meta Platforms Inc30303M102US30303M1027BBG000MM2P6205/29/2024To amend Meta Platforms, Inc.'s 2012 Equity Incentive Plan.SECTION 14A SAY-ON-PAY VOTES639300FOR63930FOR
Arcellx Inc03940C100US03940C1009BBG00QHJM4S905/24/2024To approve, on an advisory basis, the compensation of the named executive officers identified in the 2023 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote").SECTION 14A SAY-ON-PAY VOTES741000FOR74100FOR
Arcellx Inc03940C100US03940C1009BBG00QHJM4S905/24/2024To approve, on an advisory basis, the frequency of future Say-on-Pay Votes.SECTION 14A SAY-ON-PAY VOTES7410001 Year74100FOR
Nurix Therapeutics Inc67080M103US67080M1036BBG00SDJ8M7805/20/2024To approve, on a non-binding advisory basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES442000FOR44200FOR
Bicycle Therapeutics PLC088786108US0887861088BBG00P0YWPK605/16/2024To approve, on advisory basis, the compensation of our named executive officers, as disclosed in the proxy statement.SECTION 14A SAY-ON-PAY VOTES1902000FOR190200FOR
Westinghouse Air Brake929740108US9297401088BBG000BDD94005/16/2024Approve an advisory (non-binding) resolution to approve the 2023 named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES3868350FOR386835FOR
Cinemark Holdings Inc17243V102US17243V1026BBG000QDVR5305/15/2024Advisory vote to approve compensation of named executive officers.SECTION 14A SAY-ON-PAY VOTES10786350FOR1078635FOR
Cinemark Holdings Inc17243V102US17243V1026BBG000QDVR5305/15/2024Vote to approve the Cinemark Holdings, Inc. 2024 Long-Term Incentive Plan.SECTION 14A SAY-ON-PAY VOTES10786350FOR1078635FOR
KBR Inc48242W106US48242W1062BBG000P28YZ605/15/2024Advisory vote to approve KBR's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES9814250FOR981425FOR
Option Care Health Inc68404L201US68404L2016BBG000BQK48005/15/2024To approve, on a non-binding advisory basis, our executive compensation.SECTION 14A SAY-ON-PAY VOTES6862050FOR686205FOR
Option Care Health Inc68404L201US68404L2016BBG000BQK48005/15/2024To approve the Amended and Restated Option Care Health, Inc. 2018 Equity Incentive Plan.SECTION 14A SAY-ON-PAY VOTES6862050FOR686205FOR
ZoomInfo Technologies Inc98980F104US98980F1049BBG00S1HJ3M805/15/2024To approve, on an advisory, non-binding basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES58819060FOR5881906FOR
Cameco Corp13321L108CA13321L1085BBG000DSZTN605/09/2024Have a say on our approach to executive compensation (see page 8 of the management proxy circular) As this is an advisory vote, the results will not be binding on the board. Be it resolved that, on an advisory basis and not to diminish the role and responsibilities of the board of directors for executive compensation, the shareholders accept the approach to executive compensation disclosed in Cameco's management proxy circular delivered in advance of the 2024 annual meeting of shareholders.SECTION 14A SAY-ON-PAY VOTES8487100FOR848710FOR
Discover Financial Services254709108US2547091080BBG000QBR5J505/09/2024Advisory vote to approve named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES826000FOR82600FOR
KeyCorp493267108US4932671088BBG000BMQPL105/09/2024Advisory approval of executive compensation.SECTION 14A SAY-ON-PAY VOTES16573950FOR1657395FOR
Tempur Sealy International In88023U101US88023U1016BBG000PXGT6205/09/2024ADVISORY VOTE TO APPROVE THE COMPENSATION OF NAMED EXECUTIVE OFFICERS.SECTION 14A SAY-ON-PAY VOTES13353200FOR1335320FOR
Kinder Morgan Inc49456B101US49456B1017BBG0019JZ88205/08/2024Approval, on an advisory basis, of the compensation of our named executive officers, as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES38805000FOR3880500FOR
Kinder Morgan Inc49456B101US49456B1017BBG0019JZ88205/08/2024Advisory vote on the frequency with which we will hold future advisory votes on the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES388050001 Year3880500FOR
Danaher Corp235851102US2358511028BBG000BH3JF805/07/2024To approve on an advisory basis the Company's named executive officer compensation.SECTION 14A SAY-ON-PAY VOTES1003000FOR100300FOR
General Electric Co369604301US3696043013BBG000BK6MB505/07/2024Advisory Approval of Our Named Executives' Compensation.SECTION 14A SAY-ON-PAY VOTES8530950FOR853095FOR
Eli Lilly & Co532457108US5324571083BBG000BNBDC205/06/2024Approval, on an advisory basis, of the compensation paid to the company's named executive officers.SECTION 14A SAY-ON-PAY VOTES884990FOR88499FOR
Bank OZK06417N103US06417N1037BBG000QFJJW005/06/2024To approve, on an advisory, non-binding basis, the compensation of the Company's named executive officers as disclosed in the Proxy Statement.SECTION 14A SAY-ON-PAY VOTES2342000FOR234200FOR
Capital One Financial Corp14040H105US14040H1059BBG000BGKTF905/02/2024Advisory vote on our Named Executive Officer compensation ("Say on Pay").SECTION 14A SAY-ON-PAY VOTES369850FOR36985FOR
Vistra Corp92840M102US92840M1027BBG00DXDL6Q105/01/2024To approve, on a non-binding advisory basis, the 2023 compensation of the Company's named executive officers.SECTION 14A SAY-ON-PAY VOTES26977160FOR2697716FOR
Vistra Corp92840M102US92840M1027BBG00DXDL6Q105/01/2024To approve, on a non-binding advisory basis, whether the advisory stockholder vote on the compensation of named executive officers should occur every one, two or three years.SECTION 14A SAY-ON-PAY VOTES269771601 Year2697716FOR
Vistra Corp92840M102US92840M1027BBG00DXDL6Q105/01/2024To approve an amendment to the Vistra Corp. Omnibus Incentive Plan (as amended and restated, the "2016 Incentive Plan") to increase the number of shares available for issuance to plan participants under the 2016 Incentive Plan.SECTION 14A SAY-ON-PAY VOTES26977160FOR2697716FOR
Constellation Energy Corp21037T109US21037T1097BBG014KFRNP704/30/2024To consider and act on an advisory vote regarding the approval of compensation paid to named executive officers.SECTION 14A SAY-ON-PAY VOTES2151430FOR215143FOR
Grupo Financiero Galicia SA399909100US3999091008BBG000F646H304/30/2024Consideration of the Supervisory Syndics Committee's compensation.SECTION 14A SAY-ON-PAY VOTES3218630FOR321863FOR
Grupo Financiero Galicia SA399909100US3999091008BBG000F646H304/30/2024Consideration of the Board of Directors' compensation.SECTION 14A SAY-ON-PAY VOTES3218630FOR321863FOR
AES Corp/The00130H105US00130H1059BBG000C23KJ304/25/2024Approval, on an advisory basis, of the Company's executive compensation.SECTION 14A SAY-ON-PAY VOTES3147500FOR314750FOR
NRG Energy Inc629377508US6293775085BBG000D8RG1104/25/2024To approve, on a non-binding advisory basis, NRG Energy, Inc.'s executive compensation.SECTION 14A SAY-ON-PAY VOTES968850FOR96885FOR
Teck Resources Ltd878742204CA8787422044BBG000BSJTT004/25/2024To approve an advisory resolution on Teck's approach to executive compensation.SECTION 14A SAY-ON-PAY VOTES41348370FOR4134837FOR
Teck Resources Ltd878742204CA8787422044BBG000BCS9D604/25/2024To approve an advisory resolution on Teck's approach to executive compensation.SECTION 14A SAY-ON-PAY VOTES7310950FOR731095FOR
Sphere Entertainment Co55826T102US55826T1025BBG00L9HLWV812/08/2023Approval of, on an advisory basis, the compensation of our named executive officers.SECTION 14A SAY-ON-PAY VOTES2702700FOR270270FOR
Microsoft Corp594918104US5949181045BBG000BPH45912/07/2023Advisory Vote to Approve Named Executive Officer Compensation ("say-on-pay vote").SECTION 14A SAY-ON-PAY VOTES10172600FOR1017260FOR
Microsoft Corp594918104US5949181045BBG000BPH45912/07/2023Advisory Vote on the Frequency of Advisory Vote on Executive Compensation.SECTION 14A SAY-ON-PAY VOTES101726001 Year1017260FOR
News Corp65249B208US65249B2088BBG0035M2ZB711/15/2023Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTES9756000FOR975600FOR
Lamb Weston Holdings Inc513272104US5132721045BBG003CVMLQ209/28/2023Advisory Vote to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTES21111600FOR2111160FOR
Lamb Weston Holdings Inc513272104US5132721045BBG003CVMLQ209/28/2023Advisory Vote on the Frequency of Future Advisory Votes to Approve Executive Compensation.SECTION 14A SAY-ON-PAY VOTES211116001 Year2111160FOR
IVERIC bio Inc46583P102US46583P1021BBG0019K7J3107/06/2023To approve, by non-binding, advisory vote, compensation that may be paid or become payable by IVERIC to its named executive officers in connection with the Merger.SECTION 14A SAY-ON-PAY VOTES2367170FOR236717FOR
Telecom Argentina SA879273209US8792732096BBG000BL1FQ704/25/2024Consider the compensation for the Members of the Board of Directors (allocated amount: AR$ 889,453,418) for the fiscal year ended December 31,2023, which reported a computable loss according to the terms of the CNV Rules.SECTION 14A SAY-ON-PAY VOTES1430510FOR143051FOR
Telecom Argentina SA879273209US8792732096BBG000BL1FQ704/25/2024Consider the compensation to Members of the Supervisory Committee corresponding to the fiscal year ended December 31,2023. Proposal to pay of the total amount of AR$ 106,243,621.SECTION 14A SAY-ON-PAY VOTES1430510FOR143051FOR